Vimarsana
Biggest News Aggregation in the World

Page 2 - Paul Danner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Paul Danner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Paul Danner Today - Breaking & Trending Today

CB Scientific, Inc. to Convene a Special Meeting of Stockholders on Friday, January 14, 2022 - Vimarsana News

CB Scientific, Inc. to Convene a Special Meeting of Stockholders on Friday, January 14, 2022

Agenda includes transformational matters affecting the Company's position to manage impending growthESCONDIDO, CA / ACCESSWIRE / January 4, 2022 / CB Scientific, Inc. (OTC PINK: CBSC) ("CBSC" or the "Company")

CB Scientific, Inc. Announces Intent to Convene a Special Meeting of the Stockholders - Vimarsana News

CB Scientific, Inc. Announces Intent to Convene a Special Meeting of the Stockholders

Agenda to include matters necessary to better position the company for anticipated growth and developmentESCONDIDO, CA / ACCESSWIRE / November 30, 2021 / CB Scientific. Inc. (OTC PINK:CBSC) ("CBSC" or

CB Scientific, Inc. Appoints Paul Danner as Chairman - Vimarsana News

CB Scientific, Inc. Appoints Paul Danner as Chairman

The addition marks the first in a series of executive leadership enhancements intended to position CBSC for accelerated successESCONDIDO, CA / ACCESSWIRE / October 28, 2021 / CB Scientific, Inc. (OTC PINK:CBSC)

Phase One Development of Rapid COVID-19 Point of Care Test Complete - Vimarsana News

Phase One Development of Rapid COVID-19 Point of Care Test Complete

Phase One Development of Rapid COVID-19 Point of Care Test Complete Pepex Biomedical has effectively concluded first stage development efforts including successfully demonstrating working chemistry and manufacturing functionality of its existing electrochemical biosensor. Atlanta, GA, February 11, 2021 --(PR.com)-- Pepex Biomedical, Inc. (the “Company”), a leading developer of enzymatic biosensor technology, has completed the initial development phase of its forthcoming suite of immunosensor testing products designed to accurately identify COVID-19 antigens and antibodies in under 15 mi...

Source: pr.com